Girard Sharp attorneys are investigating claims that Depo-Provera, a hormone-replacement drug used primarily for contraception, may significantly increase the risk of meningioma, a type of brain tumor, bone density loss and osteoporosis, a condition causing weak and brittle bones.
Did you use Depo-Provera and were diagnosed with meningioma, osteoporosis or bone density loss? You may have a claim to significant relief.
Protect your rights by speaking with a Girard Sharp consumer protection attorney—dial (866) 981-4800 or submit your information below.
Depo-Provera Found to Increase Risk of Tumors & Bone Conditions By Over 5x
Depo-Provera is manufactured by Pfizer, one of the largest drug companies in the US. A recent study that monitored women taking Depo-Provera from 2009 to 2018 found that the drug was linked to a 5.6 times increase in the rate of meningioma. Depo-Provera has also been scientifically linked (link study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC552887/) to an increased risk of osteoporosis and bone density loss that may not be reversable.
Were you diagnosed with meningioma, osteoporosis or bone density loss while using Depo-Provera? Protect your rights by contacting a Girard Sharp attorney today.
Dial (866) 981-4800 or submit your information through the form above for a free consultation about your options.
Our Commitment to Excellence
Girard Sharp has earned national Tier 1 rankings for Mass Tort and Class Action Litigation and has been named to the U.S. News – Best Lawyers “Best Law Firms” list each year since 2013. Read about some of our results [link here].
We have substantial experience in lawsuits concerning sensitive issues and in guiding affected individuals through the litigation process with discretion. From holding pharmaceutical companies accountable for marketing birth-control pills that caused life-threatening blood clots, to obtaining over $14 million in restitution at a trial on behalf of fertility clinic patients whose frozen eggs and embryos were compromised, we have a well-established track record of successfully taking on some of the world’s largest corporations and institutions.
